$5.16
0.265.31%
At close: -
$5.49
0.336.47%
After Hours: 6:05 PM EDT
TriSalus Life Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TriSalus Life Sciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.12 | $-0.37 | 67.6 % |
Q2 | 2024-08-14 | $-0.21 | $-0.49 | 57.1 % |
Q1 | 2024-05-15 | $-0.60 | $-0.72 | 16.7 % |
Q4 | 2024-04-01 | $-1.56 | $-0.69 | -126.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $7.35M | $7.37M | -0.28 % |
Q2 | 2024-08-14 | $7.36M | $6.89M | 6.88 % |
Q1 | 2024-05-15 | $6.46M | $6.44M | 0.26 % |
Q4 | 2024-04-01 | $5.72M | $5.45M | 4.97 % |
TriSalus Life Sciences (TLSI) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.12, which beat the estimate of $-0.37.
The Actual Revenue was $7.3M, which missed the estimate of $7.4M.
Browse earnings estimates, EPS, and revenue on all stocks.